# Cryotherapy Intervention for Docetaxel-induced Nail Toxicities

> **NCT00911352** · PHASE2,PHASE3 · COMPLETED · sponsor: **Princess Alexandra Hospital, Brisbane, Australia** · enrollment: 65 (actual)

## Conditions studied

- Effects of Chemotherapy

## Interventions

- **DEVICE:** Frozen gel glove (Elasto-Gel Mitten)

## Key facts

- **NCT ID:** NCT00911352
- **Lead sponsor:** Princess Alexandra Hospital, Brisbane, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2012-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911352, "Cryotherapy Intervention for Docetaxel-induced Nail Toxicities". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00911352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*